Pseudomonas aeruginosa: metabolic allies and adversaries in the world of polymicrobial infections

被引:0
|
作者
Sachdeva, Chandni [1 ]
Satyamoorthy, Kapaettu [2 ,3 ]
Murali, Thokur Sreepathy [1 ]
机构
[1] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Publ Hlth & Genom, Manipal, Karnataka, India
[2] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal, Karnataka, India
[3] Shri Dharmasthala Manjunatheshwara SDM Univ, SDM Coll Med Sci & Hosp, Sattur, Karnataka, India
关键词
Pseudomonas aeruginosa; polymicrobial interactions; metabolites; virulence factors; host-pathogen interactions; GMP-AMP SYNTHASE; CANDIDA-ALBICANS; STAPHYLOCOCCUS-AUREUS; CYSTIC-FIBROSIS; ASPERGILLUS-FUMIGATUS; MEDIATES RESISTANCE; BIOFILM FORMATION; IMMUNE-SYSTEM; HOST-DEFENSE; DNA SENSOR;
D O I
10.1080/1040841X.2024.2397359
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa (PA), an opportunistic human pathogen that is frequently linked with chronic infections in immunocompromised individuals, is also metabolically versatile, and thrives in diverse environments. Additionally, studies report that PA can interact with other microorganisms, such as bacteria, and fungi, producing unique metabolites that can modulate the host immune response, and contribute to disease pathogenesis. This review summarizes the current knowledge related to the metabolic interactions of PA with other microorganisms (Staphylococcus, Acinetobacter, Klebsiella, Enterococcus, and Candida) and human hosts, and the importance of these interactions in a polymicrobial context. Further, we highlight the potential applications of studying these metabolic interactions toward designing better diagnostic tools, and therapeutic strategies to prevent, and treat infections caused by this pathogen. (GRAPHICS)
引用
收藏
页数:20
相关论文
共 50 条
  • [41] The Therapeutic Pipeline for Pseudomonas aeruginosa Infections
    Burrows, Lori L.
    ACS INFECTIOUS DISEASES, 2018, 4 (07): : 1041 - 1047
  • [42] Epidemiology of infections due to Pseudomonas aeruginosa
    Lepape, A
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2003, 22 (06): : 520 - 522
  • [43] PSEUDOMONAS-AERUGINOSA IN ORAL INFECTIONS
    NORD, CE
    WADSTROM, T
    SJOBERG, L
    ACTA ODONTOLOGICA SCANDINAVICA, 1972, 30 (03) : 371 - &
  • [44] PSEUDOMONAS-AERUGINOSA INFECTIONS AND HIV
    MOORE, D
    NELSON, M
    GENITOURINARY MEDICINE, 1995, 71 (05): : 336 - 336
  • [45] Therapeutic guidelines for Pseudomonas aeruginosa infections
    Giamarellou, H
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (02) : 103 - 106
  • [46] Other infections caused by Pseudomonas aeruginosa
    Santiago, EB
    Creixems, MR
    REVISTA CLINICA ESPANOLA, 1998, 198 : 30 - 36
  • [47] Pseudomonas aeruginosa Infections in Cancer Patients
    Paprocka, Paulina
    Durnas, Bonita
    Mankowska, Angelika
    Krol, Grzegorz
    Wollny, Tomasz
    Bucki, Robert
    PATHOGENS, 2022, 11 (06):
  • [48] THE ROLE OF PSEUDOMONAS-AERUGINOSA IN INFECTIONS
    NEU, HC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 : 1 - 13
  • [49] HOSPITAL INFECTIONS WITH PSEUDOMONAS-AERUGINOSA
    KRUGER, H
    MALOTTKE, R
    POTEL, J
    MEDIZINISCHE KLINIK, 1977, 72 (43) : 1803 - 1807
  • [50] Clinical features of Pseudomonas aeruginosa infections
    Sarlangue, J.
    Brissaud, O.
    Labreze, C.
    ARCHIVES DE PEDIATRIE, 2006, 13 : S13 - S16